Turn Therapeutics (TTRX) Consolidated Net Income (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Consolidated Net Income of -$3.1 million for Q1 2026, down 449.34% year-over-year from $900696.3 in Q1 2025, and down 7.5% quarter-over-quarter from -$2.9 million in Q4 2025.
Turn Therapeutics (TTRX) Consolidated Net Income (2024 - 2026) Analysis & Trends
Turn Therapeutics' Consolidated Net Income history runs 3 years deep, the most recent figure standing at -$3.1 million for Q1 2026.
- In Q1 2026, Consolidated Net Income fell 449.34% year-over-year to -$3.1 million; the TTM figure through Mar 2026 stood at -$14.2 million (changed N/A YoY), while the FY2025 annual figure was -$13.9 million, down 146.3% from the prior year.
- Consolidated Net Income for Q1 2026 stood at -$3.1 million, down from -$2.9 million in the prior quarter.
- The five-year high for Consolidated Net Income was -$470237.0 in Q4 2024, with the low at -$7.6 million in Q3 2025.
- The 3-year median for Consolidated Net Income is -$2.0 million (2024), against an average of -$2.6 million.
- The sharpest annual moves came in 2025 and 2026: Consolidated Net Income plunged 638.58% in 2025, then slumped 449.34% in 2026.
- Turn Therapeutics' Consolidated Net Income stood at -$470237.0 in 2024, then slumped by 522.47% to -$2.9 million in 2025, then declined by 7.5% to -$3.1 million in 2026.
- Business Quant data shows TTRX's Consolidated Net Income at -$3.1 million in Q1 2026, -$2.9 million in Q4 2025, and -$7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 482.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 930.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Turn Therapeutics | 285.07 Mn | 285.07 Mn | - | -12.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.23 Mn |
| Mar 31, 2026 | -3.15 Mn |
| Dec 31, 2025 | -2.93 Mn |
| Sep 30, 2025 | -7.58 Mn |
| Mar 31, 2025 | -572,775.00 |
| Dec 31, 2024 | -470,237.00 |
| Sep 30, 2024 | -1.03 Mn |